A new analysis by researchers at The University of Texas MD Anderson Cancer Center demonstrates that a combination therapy consisting of fludarabine, cytarabine and G-CSF (FLAG) plus gemtuzumab ozogamicin (GO) or idarubicin ...
Apr 23, 2026
0
2
Restoring the gut microbiome to its youthful state may hold the key to slowing aging and preventing liver cancer, one of the fastest-growing cancers worldwide, according to a study to be presented at Digestive Disease Week ...
Apr 23, 2026
0
9
Women diagnosed with cancer in pregnancy face profound, long-term emotional and financial challenges, a new study from the University of Surrey finds. Researchers discover fragmented care and inadequate support exacerbate ...
Apr 23, 2026
0
3
In a prospective validation study, researchers at The University of Texas MD Anderson Cancer Center have demonstrated that a new mathematical model called LFSPRO was effective in supporting genetic counselor decision-making ...
Apr 23, 2026
0
1
Researchers and clinicians from National Taiwan University (NTU) and NTU Hospital have compiled the first large-scale genetic database for colorectal cancer (CRC) in Taiwan. This initiative identified inherited genetic abnormalities ...
Apr 23, 2026
0
3
Cells manufacture proteins by following instructions encoded in messenger RNA, which is read in three-letter groups called codons. To translate this message, the cell uses molecules called transfer RNAs (tRNA). These act ...
Apr 23, 2026
0
3
Researchers at the University of British Columbia Faculty of Medicine have developed a new targeted cancer therapy that can precisely seek out and destroy tumor cells—showing strong results in preclinical studies that bring ...
Apr 23, 2026
0
4
Before her cancer diagnosis in early 2017, 48-year-old Caitlin Delaney, who is based in Australia, had been struggling with a troubling mix of symptoms comprising extreme fatigue, chronic sinusitis, and appetite changes including ...
Apr 23, 2026
0
3
Efforts to develop effective therapies for MYC-amplified Group 3 medulloblastoma (G3-MB) are hindered by an incomplete understanding of how MYC expression is controlled in these tumors. MYC, an oncogene, has long been considered ...
Apr 22, 2026
0
2
Researchers from the University of Cape Town's (UCT) Scientific Computing Research Unit (SCRU) have uncovered a critical molecular "switch" that drives the formation of cancer-associated antigens. The study, published in ...
Apr 22, 2026
0
6
